Exane Derivatives’s Quanta Services PWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$452K Sell
3,609
-984
-21% -$121K 0.26% 96
2022
Q1
$604K Sell
4,593
-1,055
-19% -$117K 0.17% 159
2021
Q4
$648K Buy
5,648
+386
+7% +$44.5K 0.16% 146
2021
Q3
$599K Sell
5,262
-3,094
-37% -$310K 0.14% 153
2021
Q2
$750K Buy
8,356
+6,951
+495% +$653K 0.17% 117
2021
Q1
$124K Buy
1,405
+633
+82% +$50.4K 0.04% 386
2020
Q4
$55.6K Buy
772
+310
+67% +$20.4K 0.02% 449
2020
Q3
$24.4K Buy
+462
New +$21.5K 0.01% 419
2017
Q4
Sell
-1
Closed -$37 630
2017
Q3
$37 Hold
1
﹤0.01% 542
2017
Q2
$33 Buy
+1
New +$33 ﹤0.01% 604
2016
Q4
Sell
-1
Closed -$28 675
2016
Q3
$28 Hold
1
﹤0.01% 586
2016
Q2
$23 Hold
1
﹤0.01% 521
2016
Q1
$23 Buy
+1
New +$20 ﹤0.01% 570
2015
Q4
Sell
-1
Closed -$24 555
2015
Q3
$24 Hold
1
﹤0.01% 512
2015
Q2
$29 Sell
1
-1
-50% -$29 ﹤0.01% 509
2015
Q1
$57 Sell
2
-23
-92% -$645 ﹤0.01% 499
2014
Q4
$710 Buy
+25
New +$785 ﹤0.01% 481

Other funds holding PWR

Exane Derivatives's PWR Position: Q2 2022 in Review

Exane Derivatives reduced its Quanta Services (PWR) stake by 21% in Q2 2022, selling an estimated $121K and leaving 3,609 shares worth $452K. The position accounts for 0.26% of the portfolio, ranked #96.

Exane Derivatives first reported a position in PWR in Q4 2014 and has held it in 17 quarters since. The position peaked at $750K in Q2 2021. 784 funds tracked by Wall St. Rank hold PWR as of Q2 2022.

  • Exane Derivatives held 3,609 shares of Quanta Services worth $452K as of Q2 2022.
  • Exane Derivatives sold 984 Quanta Services shares in Q2 2022, an estimated $121K.
  • Quanta Services made up 0.26% of Exane Derivatives's portfolio in Q2 2022, its #96 holding.
  • Exane Derivatives first reported a position in Quanta Services in Q4 2014 and has held it in 17 quarters since.
  • Exane Derivatives's Quanta Services position peaked at $750K in Q2 2021.
  • 784 funds tracked by Wall St. Rank held Quanta Services as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.